Here, we show that EPN3 is overexpressed in ~40% of breast cancers (BCs) and that its overexpression (associated with gene amplification in ~25% of the overexpressing cases) is an independent predictor of distant metastasis. The gene discussed is EPN3; the disease is breast cancer.